Drug intelligence / Profile preview

XiangLian

Development stage
Preclinical
Lead developer
Ministry of Science and Technology of the People’s Republic of China
Modality
Small Molecules
Administration
Vaginal, Oral, Topical
01

Overview

XiangLian is a traditional Chinese medicine (TCM) formula, commonly known as Xianglian pill or Xianglian Wan, primarily composed of the herbs Coptidis Rhizoma (Huanglian) and Aucklandiae Radix (Muxiang). It has been historically used to "eliminate damp-heat, promote the flow of qi and relieve pain" for conditions like dysentery, abdominal pain, and diarrhea. Modern research indicates its therapeutic potential in various conditions, including recurrent vulvovaginal candidiasis, tinea pedis, antibiotic-associated diarrhea, ulcerative colitis, pancreatic cancer, dyslipidemia, and colorectal cancer. Its mechanisms of action are diverse, involving the regulation of inflammation, apoptosis, metastasis, and metabolism, inhibition of PTGS1/PTGS2, promotion of autophagy via the PI3K/Akt/mTOR pathway, modulation of gut microbiota and succinate production, induction of regulatory T cells, and inhibition of M1 macrophage polarization. Key active components include berberine, which has been shown to inhibit fatty acid synthase.

Other names
Xianglian pillXianglian WanXiangLian SuppositoryXiangLian lotionXiangLian creamtablet of XianglianXLP
02

Targets

TLR4 (Toll-like receptor 4)PGHS-1 (Prostaglandin G/H Synthase 1)AKT (RAC-alpha serine/threonine-protein kinase)NeuraminidaseFASN (Fatty acid synthase)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)UCP1 (Uncoupling protein 1)mTOR (Mammalian target of rapamycin kinase)MYD88 (Myeloid differentiation primary response protein MyD88)

Beyond the preview

Go deeper on XiangLian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on XiangLian.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call